102 related articles for article (PubMed ID: 9720496)
21. Laminin 5 beta3 and gamma2 chains are frequently coexpressed in cancer cells.
Akimoto S; Nakanishi Y; Sakamoto M; Kanai Y; Hirohashi S
Pathol Int; 2004 Sep; 54(9):688-92. PubMed ID: 15363037
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
23. Proteinase activity in invasive cancer of the breast. Correlation with tumor progression.
Benítez-Bribiesca L; Martínez G; Ruíz MT; Gutiérrez-Delgado F; Utrera D
Arch Med Res; 1995; 26 Spec No():S163-8. PubMed ID: 8845643
[TBL] [Abstract][Full Text] [Related]
24. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
25. Development of liver metastasis in colorectal carcinoma. With special reference to venous invasion and basement membrane laminin.
Inada K; Shimokawa K; Ikeda T; Hayashi M; Azuma S
Acta Pathol Jpn; 1991 Mar; 41(3):240-5. PubMed ID: 1712535
[TBL] [Abstract][Full Text] [Related]
26. Laminin-5 gamma 2 chain and matrix metalloproteinase-2 may trigger colorectal carcinoma invasiveness through formation of budding tumor cells.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Izumisato Y; Goto A; Sakamoto A; Atomi Y
Anticancer Res; 2003; 23(5b):4113-9. PubMed ID: 14666611
[TBL] [Abstract][Full Text] [Related]
27. [Tissue expression of carbohydrate antigen 19-9 (CA 19-9) in adenomatous lesions of the colorectum].
Tucci GF; Grande M; Stroppa I; Federico F; Farinon AM
Chir Ital; 1999; 51(2):165-72. PubMed ID: 10514933
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin B and cystatins: evidence for a role in cancer progression.
Sloane BF
Semin Cancer Biol; 1990 Apr; 1(2):137-52. PubMed ID: 2103490
[TBL] [Abstract][Full Text] [Related]
29. Difference in cell proliferation between two structurally different lesions in colorectal adenomas: high-grade dysplasia and carcinoma in situ.
Rubio CA
Anticancer Res; 2007; 27(6C):4321-4. PubMed ID: 18214039
[TBL] [Abstract][Full Text] [Related]
30. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
[TBL] [Abstract][Full Text] [Related]
31. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
Trovato M; Vitarelli E; Grosso M; Alesci S; Benvenga S; Trimarchi F; Barresi G
Eur J Histochem; 2004; 48(3):291-7. PubMed ID: 15590419
[TBL] [Abstract][Full Text] [Related]
33. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
34. Tumor deposition of laminin-5 and the relationship with perineural invasion.
Anderson TD; Feldman M; Weber RS; Ziober AF; Ziober BL
Laryngoscope; 2001 Dec; 111(12):2140-3. PubMed ID: 11802012
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Id-1 protein is a marker in colorectal cancer progression.
Zhao ZR; Zhang ZY; Zhang H; Jiang L; Wang MW; Sun XF
Oncol Rep; 2008 Feb; 19(2):419-24. PubMed ID: 18202790
[TBL] [Abstract][Full Text] [Related]
36. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
37. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.
Eiján AM; Sandes EO; Riveros MD; Thompson S; Pasik L; Mallagrino H; Celeste F; Casabé AR
Cancer; 2003 Jul; 98(2):262-8. PubMed ID: 12872343
[TBL] [Abstract][Full Text] [Related]
38. Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum.
Cui G; Goll R; Olsen T; Steigen SE; Husebekk A; Vonen B; Florholmen J
Cancer Immunol Immunother; 2007 Jul; 56(7):985-95. PubMed ID: 17160410
[TBL] [Abstract][Full Text] [Related]
39. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells.
Rozhin J; Sameni M; Ziegler G; Sloane BF
Cancer Res; 1994 Dec; 54(24):6517-25. PubMed ID: 7987851
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
